本页面由Tiger Trade Technology Pte. Ltd.提供服务

Royalty Pharma plc

45.97
+0.61001.34%
成交量:160.09万
成交额:7,372.55万
市值:268.09亿
市盈率:25.81
高:46.37
开:45.44
低:45.26
收:45.36
52周最高:46.37
52周最低:29.66
股本:5.83亿
流通股本:3.80亿
量比:0.64
换手率:0.42%
股息:0.88
股息率:1.91%
每股收益(TTM):1.78
每股收益(LYR):1.78
净资产收益率:13.20%
总资产收益率:5.15%
市净率:4.14
市盈率(LYR):25.81

数据加载中...

2026/02/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/11

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/02/11

重要事件披露

Form 8-K - Current report
2026/02/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/22

重要事件披露

Form 8-K - Current report
2025/12/22

重要事件披露

Form 8-K - Current report
2025/12/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/05

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/11/05

重要事件披露

Form 8-K - Current report